“Once you’ve made it through lung cancer treatment, you want to make sure you catch it early if it comes back again.
“But a new study suggests that one approach to watching for a cancer’s return is being inappropriately used at many hospitals. And it isn’t helping patients survive longer, the research shows. The findings are published in the Journal of the National Cancer Institute.
“The study looked at how often survivors of lung and esophageal cancer went through a kind of imaging called PET scanning as the primary way of monitoring their condition, instead of as a backstop to other kinds of scans.
“PET scans are expensive, but potentially powerful. They let doctors see increased activity by cells inside the body — including fast-growing cancer cells — and can do so early. Many cancer patients receive PET scans as part of diagnosis, to see how advanced their cancer is, and to see how it’s responding to treatment.”
“Vaginal estrogen is safe for breast cancer survivors suffering from such urogenital symptoms as vaginal atrophy, vasomotor symptoms, and lower urinary tract infections, and there is no evidence of increased risk of cancer recurrence with the treatment, according to a statement from the American College of Obstetricians and Gynecologists (ACOG).
“However, the decision to use vaginal estrogen should be made in consultation with a woman’s oncologist, and only if ‘first-line choices’ for managing urogenital symptoms — which should be nonhormonal products such as lubricants — are ineffective for breast cancer patients, reported ACOG’s Committee on Gynecologic Practice, writing in Obstetrics and Gynecology.
“Sexual medicine specialist Lauren Streicher, MD, of Northwestern University, who was not involved with the statement, said that although the treatment clearly eases vaginal dryness, many physicians are reluctant to prescribe it for breast cancer patients. But she said the response is quite different when gynecologists are asked about it.”
“The checkpoint inhibitors pembrolizumab and nivolumab not only prolong survival in advanced melanoma patients but also maintain health-related quality of life (QoL), according to two presentations at the Society for Melanoma Research 2015 International Congress, held November 18–21 in San Francisco.
“In the international, randomized, open-label phase III KEYNOTE-006 study, the anti–programmed death-1 (PD-1) humanized monoclonal antibody pembrolizumab provided superior overall survival (OS), progression-free survival (PFS), and response, and with less high-grade toxicity compared with the cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) inhibitor ipilimumab in 834 patients with ipilimumab-naive advanced melanoma who received up to one prior therapy.”
In 1998, Dave Bjork went to the doctor for a high fever accompanied by chills so intense that he shivered even though he wore three jackets. A chest X-ray revealed pneumonia and Dave went back to his life. “I didn’t think anything of it,” he says.
But then Dave had another bout of pneumonia only a few months later, and his new X-ray and his old one had a terrible similarity. “My radiologist held up the two X-rays and showed me that the infection was in the same spot,” he says. Next came a CAT scan and a call from his doctor saying they’d found a tumor in his lung. Continue reading…
“According to the American Cancer Society, more than 70,000 people are diagnosed with melanoma each year in the United States. It is recommended that such individuals perform a thorough skin self-exam on a regular basis to look for potential disease recurrence or new melanomas. But research by Rutgers Cancer Institute of New Jersey investigators shows fewer than 15 percent of melanoma patients surveyed regularly examine all parts of their body. Rutgers Cancer Institute behavioral scientist Elliot J. Coups, PhD, an associate professor of medicine at Rutgers Robert Wood Johnson Medical School, is the lead author of the work just published in the journal Melanoma Research (doi: 10.1097/CMR.0000000000000204). He shares more about the research.”
“Weight training can be a big boost to breast cancer survivors who are trying to regain muscle and bone strength lost due to cancer treatment and physical inactivity, says a Florida State University researcher.
“In the academic journal Healthcare, FSU Professor of Exercise Science Lynn Panton details how a weight training regimen can help women who’ve survived breast cancer repair chemotherapy-weakened bodies and help them get back to living their lives.
“ ‘Cancer treatment causes this accelerated aging,’ Panton said. ‘What we are finding is that many breast cancer survivors are very weak in the upper body.’ “
“Training on skin self-examination (SSE) to aid early detection could be extra beneficial for patients with melanoma and their partners who report having low relationship quality because it gives them activities to do together, according to an article published online by JAMA Dermatology.
“Melanoma remains a significant public health concern with an estimated 73,000 new cases of invasive melanoma and more than 9,900 deaths expected to occur in 2015. Melanoma is a treatable cancer with a high survival rate if it is detected early. Individuals previously diagnosed with melanoma are 10 times more likely to develop additional melanomas, which makes them an important population on which to focus early detection. Melanomas detected during SSE are more likely to have favorable outcomes. However, many areas on the body are difficult to examine by oneself so a skin-check partner is beneficial.”
“First, there was achiness, a pain that never went away. Then, her right arm and hand began to swell, a little at first and then a lot. Then Rebecca Thomas, a breast cancer survivor five years out from surgery, chemo and radiation, was hospitalized with a raging infection.
“ ‘The swelling wasn’t bad at first and I didn’t think much of it,’ said the 65-year-old food service worker from Seattle, who was diagnosed with cancer in 1988. ‘But I got a [cut] on my finger and bacteria got in there and I ended up with a very bad case of cellulitis. It got at least three times the normal size, my whole hand and arm. After that is when the trouble really set in.’
“Thomas’ ‘trouble’ was lymphedema, a condition that impacts millions of U.S. cancer survivors every year, particularly patients who undergo lymph node dissection as part of their treatment, like actress and ‘lymphedema ambassador’ Kathy Bates.“
“Acupuncture may be a viable treatment for women experiencing hot flashes as a result of estrogen-targeting therapies to treat breast cancer, according to a new study from researchers at the Perelman School of Medicine at the University of Pennsylvania. Hot flashes are particularly severe and frequent in breast cancer survivors, but current FDA-approved remedies for these unpleasant episodes, such as hormone replacement therapies are off-limits to breast cancer survivors because they include estrogen. The results of the study are published this week in the Journal of Clinical Oncology.
” ‘Though most people associate hot flashes with menopause, the episodes also affect many breast cancer survivors who have low estrogen levels and often undergo premature menopause, following treatment with chemotherapy or surgery,’ said lead author Jun J. Mao, MD, MSCE, associate professor of Family Medicine and Community Health. ‘These latest results clearly show promise for managing hot flashes experienced by breast cancer survivors through the use of acupuncture, which in previous studies has also been proven to be an effective treatment for joint pain in this patient population.’ “